Peripheral Artery Disease Clinical Trials

Find Peripheral Artery Disease Clinical Trials Near You

Near-Infrared Diffuse Correlation Spectroscopy to Better Define the Pathophysiology of Peripheral Artery Disease

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction. Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Cases, Aim 1

‣ 18 or older

⁃ willing to participate under the conditions described in the informed consent form (ICF)

⁃ eligible to sign the ICF

⁃ established diagnosis of PAD confirmed by a physician

⁃ able to comply with the study requirements

• Cases, Aim 2

• 1\) completed Aim 1

• Controls 1) asymptomatic, with no history or diagnosis of peripheral artery disease

Locations
United States
Texas
University of Texas Arlington
NOT_YET_RECRUITING
Arlington
University of Texas at Arlington
RECRUITING
Arlington
Contact Information
Primary
Michael Nelson, PhD
michael.nelson3@uta.edu
8175130383
Backup
Rajvi Shah, MPH
rajvi.shah@uta.edu
2147557343
Time Frame
Start Date: 2025-11-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 120
Treatments
Healthy Controls
Individuals without PAD
Cases with PAD
Individuals with PAD
Sponsors
Leads: The University of Texas at Arlington

This content was sourced from clinicaltrials.gov